TCS features as ‘Leader and Star Performer’ in Everest Group report

19 Aug 2017 Evaluate

Tata Consultancy Services (TCS) has been recognized as a Leader and Star Performer for Life Sciences Clinical and R&D IT Services by leading advisory and research firm, Everest Group, in its report, ‘Life Sciences Clinical and R&D IT Services - Service Provider Landscape with PEAK Matrix Assessment 2017.’

Everest Group acknowledged TCS’ strong foothold in the pharmaceutical and medical devices sector and a growing business presence with biotechnology firms. The report highlights TCS’ strong growth in strategic clinical and R&D space with solutions such as Advanced Drug Development Platform and Connected Clinical Trials and consistent execution excellence. In addition, the company is recognized for its significant investments in gene-based therapeutics and connected healthcare and an emerging platform play in clinical and R&D areas.

Tata Consultancy Services (TCS) is an IT services, consulting and business solutions organization that delivers real results to global business, ensuring a level of certainty no other firm can match. The company offers a consulting-led, integrated portfolio of IT, BPS, infrastructure, engineering and assurance services.

TCS Share Price

3235.70 27.70 (0.86%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 3235.70
Infosys 1595.95
HCL Tech. 1668.10
Wipro 263.10
Tech Mahindra 1585.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×